UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

T-cell immunity in the induction and maintenance of a tumour dormant state

Seminars in cancer biology, 2001-08, Vol.11 (4), p.285-295

Schirrmacher, V

2001

Volltextzugriff (PDF)

Efficiency of adjuvant active specific immunization with Newcastle disease virus modified tumor cells in colorectal cancer patients following resection of liver metastases: results of a prospective randomized trial

Cancer Immunology, Immunotherapy, 2009-01, Vol.58 (1), p.61-69

2009

Volltextzugriff (PDF)

Human tumor cell infection by Newcastle Disease Virus leads to upregulation of HLA and cell adhesion molecules and to induction of interferons, chemokines and finally apoptosis

International journal of oncology, 2002-07, Vol.21 (1), p.85

2002

Volltextzugriff (PDF)

Harnessing oncolytic virus-mediated immunity

2015

Volltextzugriff (PDF)

Recombinant Newcastle disease virus (NDV) with inserted gene coding for GM-CSF as a new vector for cancer immunogene therapy

Gene therapy, 2007-12, Vol.14 (23), p.1639-1649

2007

Volltextzugriff (PDF)

Clinical trials of antitumor vaccination with an autologous tumor cell vaccine modified by virus infection: improvement of patient survival based on improved antitumor immune memory

Cancer Immunology, Immunotherapy, 2005-06, Vol.54 (6), p.587-598

Schirrmacher, Volker

2005

Volltextzugriff (PDF)

Human tumor cell modification by virus infection : an efficient and safe way to produce cancer vaccine with pleiotropic immune stimulatory properties when using Newcastle disease virus

Gene therapy, 1999, Vol.6 (1), p.63-73

1999

Volltextzugriff (PDF)

Astrophysical dust formation under the influence of temperature fluctuations : A general stochastic approach and its application to AGB winds

Astronomy and astrophysics (Berlin), 2008-12, Vol.491 (3), p.643-662

2008

Volltextzugriff (PDF)

Antitumor effects of Newcastle Disease Virus in vivo: local versus systemic effects

International journal of oncology, 2001-05, Vol.18 (5), p.945

2001

Volltextzugriff (PDF)

Tumour cell-dendritic cell fusion for cancer immunotherapy: comparison of therapeutic efficiency of polyethylen-glycol versus electro-fusion protocols

European journal of clinical investigation, 2002-03, Vol.32 (3), p.207-217

2002

Volltextzugriff (PDF)

Dendritic cells pulsed with viral oncolysates potently stimulate autologous T cells from cancer patients

International journal of oncology, 2002-10, Vol.21 (4), p.685

2002

Volltextzugriff (PDF)

Newcastle disease virus: a promising vector for viral therapy, immune therapy, and gene therapy of cancer

Methods in molecular biology (Clifton, N.J.), 2009, Vol.542, p.565

2009

Volltextzugriff (PDF)

Multimodal immunotherapy for DIPG: status today

Klinische Pädiatrie, 2016-11, Vol.228 (6/07)

2016

Volltextzugriff (PDF)

Second international conference on cancer vaccines/adjuvants/delivery for the next decade (CVADD): Heidelberg, Germany, 10–12 October 2007

Cancer Immunology, Immunotherapy, 2008-09, Vol.57 (9), p.1421-1427

2008

Volltextzugriff (PDF)

Tumor-cell number and viability as quality and efficacy parameters of autologous virus-modified cancer vaccines in patients with breast or ovarian cancer

Journal of clinical oncology, 1997-04, Vol.15 (4), p.1354-1366

1997

Volltextzugriff (PDF)

Polarization of human monocyte-derived dendritic cells to DC1 by in vitro stimulation with Newcastle Disease Virus

Journal of B.U. ON., 2009-09, Vol.14 Suppl 1, p.S111

2009

Volltextzugriff (PDF)

Immunization with virus-modified tumor cells

Seminars in oncology, 1998-12, Vol.25 (6), p.677-696

1998

Volltextzugriff (PDF)

Generation of dendritic cells from human bone marrow mononuclear cells: advantages for clinical application in comparison to peripheral blood monocyte derived cells

International journal of oncology, 2002-02, Vol.20 (2), p.247

2002

Volltextzugriff (PDF)

Expression of RIG-I, IRF3, IFN-beta and IRF7 determines resistance or susceptibility of cells to infection by Newcastle Disease Virus

International journal of oncology, 2009-04, Vol.34 (4), p.971-982

2009

Volltextzugriff (PDF)

Newcastle disease virus-infected intact autologous tumor cell vaccine for adjuvant active specific immunotherapy of resected colorectal carcinoma

Clinical cancer research, 1996-01, Vol.2 (1), p.21-28

1996

Volltextzugriff (PDF)

Bone marrow as a priming site for T-cell responses to blood-borne antigen

Nature medicine, 2003-09, Vol.9 (9), p.1151-1157

2003

Volltextzugriff (PDF)

In situ analysis of tumor-specific CTL effector and memory responses elicited by tumor vaccination

International journal of oncology, 1999-08, Vol.15 (2), p.217

Schirrmacher, V

1999

Volltextzugriff (PDF)

Interaktionen zwischen Tumorantigen-reaktiven T-Zellen des Knochenmarks und Tumorzellen bei Patientinnen mit Mammakarzinom

Geburtshilfe und Frauenheilkunde, 2006-11, Vol.66 (11), p.1059-1065

2006

Volltextzugriff (PDF)

Specific immune recognition of pancreatic carcinoma by patient-derived CD4 and CD8 T cells and its improvement by interferon-γ

International journal of oncology, 2006-06, Vol.28 (6), p.1419-1428

2006

Volltextzugriff (PDF)

Tumor selective replication of Newcastle disease virus: Association with defects of tumor cells in antiviral defence

International journal of cancer, 2006-07, Vol.119 (2), p.328-338

2006

Volltextzugriff (PDF)

1 – 25 von 464

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(383)
Mit Volltextzugriff
(355)

Publikationsform

Sprache

Englisch
(436)
Deutsch
(29)

Erscheinungsjahr

n.n

Thema

Animals
(255)
Science & Technology
(247)
Life Sciences & Biomedicine
(236)
Mice
(216)
Biological And Medical Sciences
(147)
Oncology
(145)
Humans
(120)
Medical Sciences
(117)
Mice, Inbred Dba
(105)
Tumors
(76)
Cell Line
(60)
Female
(59)
Immunology
(58)
T-Lymphocytes - Immunology
(57)
Neoplasm Metastasis
(56)
Immunotherapy
(42)
Newcastle Disease Virus
(39)
Tumor Cells, Cultured
(39)
Lymphoma - Immunology
(38)
Fundamental And Applied Biological Sciences. Psychology
(36)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

T-cell immunity in the induction and maintenance of a tumour dormant state

Efficiency of adjuvant active specific immunization with Newcastle disease virus modified tumor cells in colorectal cancer patients following resection of liver metastases: results of a prospective randomized trial

Human tumor cell infection by Newcastle Disease Virus leads to upregulation of HLA and cell adhesion molecules and to induction of interferons, chemokines and finally apoptosis

Harnessing oncolytic virus-mediated immunity

Recombinant Newcastle disease virus (NDV) with inserted gene coding for GM-CSF as a new vector for cancer immunogene therapy

Clinical trials of antitumor vaccination with an autologous tumor cell vaccine modified by virus infection: improvement of patient survival based on improved antitumor immune memory

Human tumor cell modification by virus infection : an efficient and safe way to produce cancer vaccine with pleiotropic immune stimulatory properties when using Newcastle disease virus

Astrophysical dust formation under the influence of temperature fluctuations : A general stochastic approach and its application to AGB winds

Antitumor effects of Newcastle Disease Virus in vivo: local versus systemic effects

Tumour cell-dendritic cell fusion for cancer immunotherapy: comparison of therapeutic efficiency of polyethylen-glycol versus electro-fusion protocols

Dendritic cells pulsed with viral oncolysates potently stimulate autologous T cells from cancer patients

Newcastle disease virus: a promising vector for viral therapy, immune therapy, and gene therapy of cancer

Multimodal immunotherapy for DIPG: status today

Second international conference on cancer vaccines/adjuvants/delivery for the next decade (CVADD): Heidelberg, Germany, 10–12 October 2007

Tumor-cell number and viability as quality and efficacy parameters of autologous virus-modified cancer vaccines in patients with breast or ovarian cancer

Polarization of human monocyte-derived dendritic cells to DC1 by in vitro stimulation with Newcastle Disease Virus

Immunization with virus-modified tumor cells

Generation of dendritic cells from human bone marrow mononuclear cells: advantages for clinical application in comparison to peripheral blood monocyte derived cells

Expression of RIG-I, IRF3, IFN-beta and IRF7 determines resistance or susceptibility of cells to infection by Newcastle Disease Virus

Newcastle disease virus-infected intact autologous tumor cell vaccine for adjuvant active specific immunotherapy of resected colorectal carcinoma

Bone marrow as a priming site for T-cell responses to blood-borne antigen

In situ analysis of tumor-specific CTL effector and memory responses elicited by tumor vaccination

Interaktionen zwischen Tumorantigen-reaktiven T-Zellen des Knochenmarks und Tumorzellen bei Patientinnen mit Mammakarzinom

Specific immune recognition of pancreatic carcinoma by patient-derived CD4 and CD8 T cells and its improvement by interferon-γ

Tumor selective replication of Newcastle disease virus: Association with defects of tumor cells in antiviral defence

Suchergebnisse filtern